Develop Service Line Strategies
Analyze the Competitive Landscape
Anticipate Future Patient Needs
Identify Sites To Capture Demand
Drive Loyalty Across the Patient Journey
Leverage Price Transparency Insights
Retain Patients in Your Network
Match Provider Supply to Demand
Acquire Commercial Patients
Capture Outpatient Demand
Target High-Value HCPs
Strengthen Provider Networks
We collect and organize the industry’s most comprehensive healthcare datasets.
See demand, supply and yield across the U.S. health economy
Validated Data for 2.9M Practitioners
Episodes of Care for 300M Patients
Negotiated Rates for Any Service at Any Location
Flexible solutions to fit your specific needs and workflow
Free resources to help health economy stakeholders use our products and data
Answer Key Questions in Seconds
Health Economy Survival Strategies
Custom Enterprise-Level Analyses
Product Guides and Feature Releases
Inform Data-Driven Strategies
How We Tackle Technical Problems
Data-Driven Benchmarking Tool
Strategic guidance and commentary from our CEO, Hal Andrews
Annual fact-based analysis of trends shaping the health economy
An essential resource to survive healthcare’s negative-sum game
Develop Service Line Strategies
Analyze the Competitive Landscape
Anticipate Future Patient Needs
Identify Sites To Capture Demand
Drive Loyalty Across the Patient Journey
Leverage Price Transparency Insights
Retain Patients in Your Network
Match Provider Supply to Demand
Acquire Commercial Patients
Capture Outpatient Demand
Target High-Value HCPs
Strengthen Provider Networks
We collect and organize the industry’s most comprehensive healthcare datasets.
See demand, supply and yield across the U.S. health economy
Validated Data for 2.9M Practitioners
Episodes of Care for 300M Patients
Negotiated Rates for Any Service at Any Location
Flexible solutions to fit your specific needs and workflow
Answer Key Questions in Seconds
Custom Enterprise-Level Analyses
Inform Data-Driven Strategies
Free resources to help health economy stakeholders use our products and data
Health Economy Survival Strategies
Product Guides and Feature Releases
How We Tackle Technical Problems
Data-Driven Benchmarking Tool
Strategic guidance and commentary from our CEO, Hal Andrews
Annual fact-based analysis of trends shaping the health economy
An essential resource to survive healthcare’s negative-sum game
With Americans delaying, and in many cases foregoing, preventive and acute care (e.g., non-emergent surgeries) for an extended period due to the COVID-19 pandemic, an increasing burden of disease is likely. While the magnitude of the pandemic’s impact on downstream health outcomes (e.g., cancers diagnosed at later stages) will not be fully revealed for many years, current indications warrant near-term interventions.
Many survey-, claims- and EHR-based studies have attempted to quantify the delays of certain preventive screenings.1,2,3,4,5,6 For example, the National Cancer Institute projects an excess of 10,000 deaths attributable to colorectal and breast cancer from 2020 to 2030.7 However, current research has been limited (i.e., reliance on survey data alone, limited population segment, singular market or coverage source, and incomplete view of screening types) in its study scope.
The importance of preventive measures in detecting and treating cancer is well established. To determine the extent to which Americans delayed cancer screenings, we examined cancer screenings recommended by the U.S. Preventive Services Task Force (USPSTF) for certain adult populations for the following cancers: lung, colorectal, breast, and cervical.8,9,10,11,12 We limited the analysis to patients ages 18 and older without a personal history of cancer and with at least three years of continuous insurance coverage. For this patient cohort, we calculated the annual utilization rate of the recommended screening types (e.g., colonoscopy, blood-based screenings, and stool-based screenings for colorectal cancer) for each distinct cancer between 2017 and 2021. We then calculated percent change in new cancer diagnoses within the same period.
Screenings for these four cancer types declined in volume from 2019 to 2020, and again from 2020 to 2021 (Figure 1). Despite a nationally observed trend of females ages 20-49 consuming more primary care, cervical cancer screenings, which are recommended for females ages 21 to 65, declined most dramatically from 2019 to 2020 (-26.5%) and continued to decline from 2020 to 2021 (-11.3%). Consistent with these findings, cervical cancer diagnoses also declined more than the other three cancer types, reflecting the magnitude of female patients remaining undiagnosed.
Conversely, lung cancer screenings and diagnoses declined the least during pandemic years. Of note, the recommended population for lung screenings is more limited, spanning adults ages 50 to 80 with a maximum 15-year smoking history. While the analysis was limited to lung cancer screenings via low dose computed tomography, we separately observed minimal declines in general chest x-ray volumes (-6% in 2020 and -3% in 2021). Therefore, the smaller decline in lung cancer diagnoses could likely be correlated with x-rays performed for non-screening purposes (e.g., pneumonia, COVID-19, chest injury, etc.). While screenings for all four cancer types declined from 2019 to 2020 and again from 2020 to 2021, colorectal cancer screenings declined the least in 2021 (–0.9%).
Developing an effective response to the national decline in cancer screenings requires market-level analysis to understand which patients in which markets are most likely to have delay screenings. This information will enable providers to assess shifts in incidence of disease, and corresponding changes in service demand, which are the cornerstone of effective resource allocation. Demand trends paired with insight into the demographics, psychographics, preferences, and motivations of patients who have foregone preventive screenings is crucial to successful re-engagement. Industry stakeholders who fail to develop dynamic demand forecasting capabilities to assess the impact of deferred care, excess deaths in younger populations, population migration, and shifting delivery preferences on a continual basis will be unprepared to thrive in the post-pandemic health economy.
Thanks to Kelly Boyce and Katie Patton for their research support.